ACCUSTEM SCIENCES, INC.
Cash Flow Statement
| Line Item | Sep 2023 | Jun 2023 | Mar 2023 | Sep 2022 | Jun 2022 | Mar 2022 | Sep 2021 | Jun 2021 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-598.5K | $-372.8K | $-833.3K | $-899.1K | $-1.1M | $-790.5K | $-62.7K | $-50.5K |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $907 | $907 | $908 | $907 | $830 | $677 | $0 | $0 |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $19.9K | — | $26.2K | $38.0K | — | $17.0K | — | — |
| Net Cash from Operating Activities | $-351.6K | $-522.9K | $-446.1K | $-555.3K | $-1.0M | $372.0K | — | — |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | $0 | $2.8K | $8.2K | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | — | — | $-8.2K | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | — | $-107.3K | — | — | $2.9M | — | — |
| Net Change in Cash | — | — | $-553.3K | — | — | $3.2M | — | — |
| Free Cash Flow | — | — | — | $-555.3K | $-1.0M | $363.8K | — | — |